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Abstract
Background: Standardization of analytical approaches and reporting methods via community-wide collaboration can 
work synergistically with web-tool development to result in rapid community-driven expansion of online data 
repositories suitable for data mining and meta-analysis. In metabolomics, the inter-laboratory reproducibility of gas-
chromatography/mass-spectrometry (GC/MS) makes it an obvious target for such development. While a number of 
web-tools offer access to datasets and/or tools for raw data processing and statistical analysis, none of these systems 
are currently set up to act as a public repository by easily accepting, processing and presenting publicly submitted GC/
MS metabolomics datasets for public re-analysis.
Description: Here, we present MetabolomeExpress, a new File Transfer Protocol (FTP) server and web-tool for the 
online storage, processing, visualisation and statistical re-analysis of publicly submitted GC/MS metabolomics datasets. 
Users may search a quality-controlled database of metabolite response statistics from publicly submitted datasets by a 
number of parameters (eg. metabolite, species, organ/biofluid etc.). Users may also perform meta-analysis comparisons 
of multiple independent experiments or re-analyse public primary datasets via user-friendly tools for t-test, principal 
components analysis, hierarchical cluster analysis and correlation analysis. They may interact with chromatograms, 
mass spectra and peak detection results via an integrated raw data viewer. Researchers who register for a free account 
may upload (via FTP) their own data to the server for online processing via a novel raw data processing pipeline.
Conclusions: MetabolomeExpress https://www.metabolome-express.org provides a new opportunity for the general 
metabolomics community to transparently present online the raw and processed GC/MS data underlying their 
metabolomics publications. Transparent sharing of these data will allow researchers to assess data quality and draw 
their own insights from published metabolomics datasets.
Background
The rapidly growing field of metabolomics aims to moni-
tor the levels of as many metabolites as possible in living
systems as they respond to genetic and/or environmental
perturbations. A variety of analytical technologies have
been applied to metabolomics studies. However, GC/MS
is by far the most commonly employed technology. Rea-
sons for this include its relative affordability, sensitivity
and reproducibility. GC/MS is therefore a particularly
attractive target platform for development of web-based
tools to support community-scale comparisons and min-
ing of raw and processed metabolomics data.
Before biological insights derived from metabolomics-
based studies can be communicated, they must first be
extracted from raw instrumental datasets [1]. Raw GC/
MS metabolomic datasets are typically large and complex
in nature, frequently comprised of tens to hundreds of
data files - each containing convoluted signals for hun-
dreds to thousands of analytes. Sophisticated algorithms
are therefore required to identify and quantify signals
corresponding to biologically relevant analytes and
obtain a quantitative description of the metabolic
effect(s) associated with the experimental factor(s) of
interest [1]. This data extraction process may be broken
down into a number of general steps:
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Page 2 of 131. Detection of analytically useful signal features (ie. 
'peaks')
2. Identification of biologically relevant signal features 
by matching against a reference library of known sig-
nal characteristics for biological analytes.
3. Assignment of some quantitative signal measure-
ment to each identified biological analyte.
4. Construction of a [Metabolite x Sample] data 
matrix, usually with some form of data normalization 
against internal standard(s) and/or biological sample 
mass/volume/amount.
5. Use of statistical and exploratory data analysis tools 
to determine the effect(s) of experimental factors on 
metabolite levels.
6. Interpretation of observed metabolite-level 
changes in the context of prior knowledge about the 
metabolic system under investigation (eg. by visual 
mapping of observed metabolite level changes onto 
metabolic pathway diagrams).
A general lack of software for carrying out the above
data analysis steps quickly and easily has been one of the
greatest challenges hampering the establishment of
metabolomics as a mainstream technique. This challenge
has triggered widespread efforts to develop data process-
ing software tailored to the needs of metabolomics
researchers, resulting in a variety of specialised open-
source and proprietary tools now being available. In most
cases, these packages do not perform every step of the
metabolomics data processing workflow and therefore
require transfer of data to and from third party software.
For example, some tools such as AMDIS [2], XCMS and
XCMS2 [3,4], MetaQuant [5], MetAlign [6], Metabolite-
Detector [7], MSFACTs [8], MET-IDEA [9] and Tag-
Finder [10] focus on raw data pre-processing, peak
detection and/or quantification but provide relatively lit-
tle functionality to aid statistical analysis or biological
interpretation. On the other hand, other tools such as
MetaFIND [11], TICL [12], MetaboAnalyst [13] and
MeltDB [14] provide relatively little or no raw signal pro-
cessing functionality of their own but focus more on bio-
logical interpretation via multivariate explorative- and
statistical-analysis of pre-processed datasets produced by
third-party software packages.
It has been demonstrated in the microarray field that
standardization of analytical approaches and reporting
methods via community-wide collaboration and enforce-
ment by scientific journals can work synergistically with
web-tool development to result in rapid community-
driven expansion of online data repositories suitable for
data mining and meta-analysis. While GC/MS provides
the reproducibility required to support a similar commu-
nity effort in metabolomics, there have only been a few
reports on systems designed to undertake this (eg. the
SetupX database [15] and the Golm Metabolome Data-
base (GMD, [16]) but each have limitations, for example,
requiring propriety software for data processing or lim-
ited opportunities for public submissions.
Here, we introduce MetabolomeExpress, a new web-
tool for the online storage, processing, visualization and
re-analysis of publicly-submitted raw and processed GC/
MS metabolomics datasets. The MetabolomeExpress
web-server application https://www.metabolome-express
.org was designed to perform three main functions. The
first was to centrally store complete GC/MS metabolom-
ics datasets (including raw data, processed data, experi-
mental metadata and GC/MS reference libraries) in a way
that makes them highly accessible and useful to the public
without requiring them to download and locally repro-
cess the enormous amounts of data (frequently > > 1 GB)
that constitute the typical GC/MS metabolomics dataset.
The second function was to provide researchers with
cost-free online access to a powerful raw data processing
pipeline that extracts biological information from raw
GC/MS data with minimal effort. The third function was
to store metabolite response statistics in a central data-
base that provides tools enabling the searching, compari-
son and verification of results. Registration is free for
non-commercial use.
Construction and content
Structural overview
In a structural sense, MetabolomeExpress is comprised of
four interacting layers. The first is an FTP-accessible
repository system on the server file system that stores raw
and processed GC/MS datasets. The second layer is a
simple MySQL database containing three core tables: i) a
table of highly annotated pre-processed metabolite
response statistics with references to underlying data
including raw data signals contained in files in the file
system; ii) a table linking ~100,000 commonly used
metabolite names to their unique InChI structural identi-
fier strings; and iii) a table linking InChI-encoded chemi-
cal structures to a variety of biochemical, bioinformatic
and physicochemical attributes. Most of the information
in the latter two database tables was obtained by parsing
the file 'metabocards.txt' http://www.hmdb.ca/public/
downloads/current/metabocards.zip representing Ver-
sion 2.5 of the publicly available Human Metabolome
Database [17]. A number of missing plant metabolites
have been added since and curation of the metabolite
information tables will be an ongoing process. The
MySQL database also contains a variety of tables storing
different ontologies and controlled vocabulary terms.
The third layer of MetabolomeExpress consists of a set of
novel server-side data processing modules implemented
in PHP http://www.php.net and R http://www.r-proj-
ect.org. The fourth structural layer is a JavaScript-based
web interface that provides integrated access to all the
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Page 3 of 13data-processing, -visualisation and -analysis tools. See
Figure 1 for a structural overview. Usage instructions and
finer structural details are presented in the Metabolome-
Express Users Manual (additional file 1 with updates
available from the MetabolomeExpress website) while a
detailed commentary on the FTP repository system, data
and metadata formats and controlled vocabularies can be
found in additional file 2.
The MetabolomeExpress database of metabolite response 
statistics
One of the central purposes of a metabolomics database
is to store treatment:control metabolite signal intensity
ratio statistics in a central database and provide tools to:
i) search for metabolic phenotypes of interest; ii) compare
the results of different experiments; and iii) manually ver-
ify original interpretations of raw data. For this purpose,
MetabolomeExpress uses a simple database table con-
taining columns for statistical information and a wide
variety of administrative, biological and technical meta-
data. The database currently contains > 9500 metabolite
ratio statistics derived from 11 experiments published in
8 articles in high-ranking plant science journals [18-25]
and all future datasets published by our group will be dis-
seminated in this way. We also plan to proactively gather
and incorporate metabolite response data from the litera-
ture into the database.
Quality control of datasets submitted to the 
MetabolomeExpress database of metabolite response 
statistics
Any user with a complete dataset stored in a Metabolom-
eExpress FTP repository may submit this dataset to be
imported into the main statistical database. The quality
control model used by MetabolomeExpress follows
essentially the same principles as the major microarray
data repositories. There is no requirement for data to be
processed with the MetabolomeExpress data processing
pipeline, as long as all the required data is provided in the
correct formats. The MetabolomeExpress team does not
make any subjective assessment of the quality of data or
the scientific merit of a submitted experiment, nor does
the data need to be published in a peer-reviewed journal.
Rather, quality control is totally objective (carried out
Figure 1 Structural overview of the MetabolomeExpress webserver. MetabolomeExpress consists of four interacting layers: i) an FTP repository; 
ii) an SQL database; iii) a set of server-side data-processing modules; and iv) a web-interface. The contents and general structure of each layer are in-
dicated schematically. Further details are provided in the main text.
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Page 4 of 13automatically by a computer script) and serves only to
ensure that the dataset provided is complete (ie. it
includes: a correctly completed metadata file, all raw data
files, peak lists, a library match report, a normalised data
matrix and a statistical results file - all formatted cor-
rectly). The validation script uses human-readable 'vali-
dation template' files defining reporting requirements
and controlled vocabularies for major metabolomics
research areas (eg. plant, animal, bacterial, fungal and
environmental) and model systems with highly-devel-
oped bioinformatics resources (eg. Arabidopsis thaliana,
rice, human, mouse, Escherichia coli and Saccharomyces
cerevisiae). These templates have been designed to facili-
tate reporting according to recommendations of the
Metabolomics Standards Initiative (MSI; http://msi-
workgroups.sourceforge.net/). Currently implemented
templates are available from the MetabolomeExpress
website while instructions for their interpretation are
provided in the MetabolomeExpress User's Guide (addi-
tional file 1). If a submitted dataset is cleared by the vali-
dation script, a final security check is made by the
MetabolomeExpress curator before results are imported
into the database.
Utility
Overview of the MetabolomeExpress web interface
The MetabolomeExpress web interface provides two
main tools - Experiment Explorer and Database Explorer.
Experiment Explorer is used to process and analyse raw
and processed experimental datasets located in user FTP
repositories while Database Explorer is used to interact
with the contents of the metabolite response statistics
database and visualise the contents of shared GC/MS ref-
erence libraries. A navigation tree allows contents of the
FTP repositories to be browsed, downloaded or loaded
into Experiment Explorer. See Figure 1 for an overview of
the web-interface.
The raw data viewer
One of the distinguishing features of MetabolomeExpress
compared to other available GC/MS metabolomics web-
tools is its Raw Data Viewer tool (a component of Experi-
ment Explorer). A key goal of the project was to provide
raw data interaction capability comparable to that offered
by modern desktop chromatogram analysis programs.
The current version of the viewer has two windows: one
for displaying chromatograms and one for displaying
arbitrary mass-spectral scans. One or more chromato-
grams may be simultaneously overlaid in the viewer and
two 'colour-channels' are available so that two sets of
chromatograms may be compared. Peak detection and/or
library matching results may also be overlaid on chro-
matograms.
To our knowledge, MeltDB [14] is the only other web
application currently featuring online GC/MS chromato-
gram visualisation. The MetabolomeExpress raw data
viewer offers a number of advantages over the MeltDB
chromatogram view. These include abilities to: i) visualise
arbitrary MS scans and extracted ion chromatograms
(EICs) as opposed to only pre-processed spectra and total
ion chromatograms (TICs); ii) zoom in and out on chro-
matograms to visualise fine chromatographic details; iii)
overlay multiple chromatograms in a conventional side-
on line graph format. Another unique feature of our
viewer is a chromatographic statistical scan tool that
highlights retention time regions (MS scans) that show a
statistically significant difference in signal intensity (and
an intensity ratio greater than a user-specified threshold)
between the two chromatogram sets loaded into the two
colour channels. This is useful for rapidly locating peaks
corresponding to differentially expressed metabolites
independently of peak detection and library matching.
Overview of the MetabolomeExpress data processing 
pipeline
As a GC/MS data processing and analysis pipeline,
MetabolomeExpress provides tools for chromatographic
peak detection, peak identification (library matching),
data matrix construction and a range of statistical and
multivariate analysis tools including t-test, principal
components analysis (PCA) and hierarchical clustering
analysis (HCA). The basic mechanics and validation of
each of these tools is described briefly in the sections
below while detailed algorithm descriptions and a dem-
onstration of the use of each tool are provided in the
MetabolomeExpress User's Guide (additional file 1). See
Figure 2 for a flow diagram of the data processing pipe-
line.
Chromatographic peak detection
The aim of chromatographic peak detection is to capture
useful information about analytically important instru-
ment signals (ie. chromatographic peaks) while discard-
ing signals devoid of useful analytical information (such
as baseline noise). For this purpose, MetabolomeExpress
uses a simple yet highly effective slope-based peak detec-
tion algorithm (PeakFinder) to detect chromatographic
peaks in all extracted ion chromatograms and generate,
for each raw data file, a corresponding tab-delimited peak
list report file. The algorithm may be passed a number of
settings that tailor the algorithm to suit particular chro-
matographic and mass spectral conditions. These
include: i) a minimum 'slope' threshold that a signal must
exceed in order to be considered as possibly being part of
a peak; ii) minimum peak height; iii) minimum peak
width; iv) minimum peak area; and v) a minimum peak
purity factor (defined as the proportion of total peak area
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the optimal settings for a given type of data have been set,
no further adjustment is required as long as no major
changes to mass spectral or chromatographic protocols
have been made. A detailed description of the algorithm's
mechanics is presented in the MetabolomeExpress User's
Guide (additional file 1).
To validate the PeakFinder algorithm, we first empiri-
cally determined the optimal parameter settings for
detecting as many real chromatographic peaks as possible
while minimising the number of false peak detections
where no obvious chromatographic peak was present. We
then compared the output of PeakFinder (additional file
3) with that of the widely used proprietary software pack-
age, ChemStation (Agilent Technologies, additional file
3), under default settings. To do this, we processed the
same chromatogram (the m/z = 73 extracted ion chro-
matogram from the analysis of a complex metabolite
standard mixture, additional file 3) with each algorithm
and manually aligned peak detection results correspond-
ing to the same peaks. PeakFinder detected a total of 129
peaks, which included 74 (96%) of the 77 EIC peaks
detected by the ChemStation algorithm plus an addi-
tional 55 peaks not reported by ChemStation (additional
file 3). Visual examination of peak detection results over-
laid on the chromatogram revealed that all the peaks
detected by ChemStation and 115 (90%) of the peaks
detected by PeakFinder were clear and valid peak integra-
tions while, of the 129 peaks detected by PeakFinder, 7
(5%) were partial but otherwise valid integrations of very
small and noisy peaks, 4 (3%) were detections of very
small signal features that were difficult to discern from
baseline noise and 3 (2%) were clear false positive detec-
tions in regions of baseline noise. Increasing the mini-
mum peak purity factor from 2 to 6 removed all but one
false-integration. However, this increased stringency
came at the expense of 33 valid integrations. Importantly,
PeakFinder still outperformed ChemStation by 11 valid
integrations under these settings.
Given that MetabolomeExpress library matching (sub-
sequent to EIC peak detection) requires both correct
retention index and multiple ions with correct intensity
ratios and that analyte quantification is based on carefully
selected specific quantifier ions (which are likely to be
relatively abundant in positively matched spectra), it is
highly unlikely that the occasional false integration of
near-baseline signal features will end up affecting final
results. We therefore recommend accepting the above
'false-positive' EIC integration rate of ≤ 10% for the sake
of gaining a 40% increase in the number of 'true-positive'
integrations. To further validate PeakFinder, we per-
formed linear regressions to determine the correlations
(R2 values) between PeakFinder- and ChemStation-
reported retention times and peak areas. Regression of
Figure 2 Overview of the MetabolomeExpress data processing pipeline. Data flows through the MetabolomeExpress pipeline are illustrated 
schematically as a series of processing steps. File formats generated at each processing stage are indicated in brackets. Further details are provided in 
the main text.
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L - A la n in e  
( 2 T M S ) _I D 15 _ RI 10 8Z 1 1 6
1 2 . 5 5 1 1 0 8 0 . 9 1 1 6 0 . 3 1 0 . 1 2 0 . 0 3 0 . 0 7 0 . 0 9 0 . 0 3 0 . 1 4 0 . 0 9 0 . 9 8 0 . 4 1 0 . 0 7 0 . 6 5 0 . 0 7 0 . 2 2 0 . 0 3 1 0 . 0 1 0 . 0 1 0 . 0 3 0 . 1 1 0 . 1 7 0 . 0 1 0 . 0 1 0 . 3 3 0 . 5 9 0 . 0 1 0 . 0 1
[ P h o s p h o nic  a c id , m
b is ( t r im e th y lsily l)  eM S 5 2 ,  
R I 1 0 9 1 . 2 ]_ ID 16 _ RI
M Z 3 3 2
1 2 . 7 9 7 1 0 9 1 . 7 3 3 2 0 . 5 3 0 . 9 1 0 . 7 7 0 . 3 9 0 . 2 8 0 . 1 7 0 . 2 8 0 . 1 9 1 0 . 4 0 . 4 3 0 . 5 4 0 . 1 5 0 . 4 4 0 . 1 4 0 . 5 1 0 . 1 3 0 . 3 2 0 . 3 0 . 2 4 0 . 4 9 0 . 0 8 0 . 1 6 0 . 1 5 0 . 6 1 0 . 2 0 . 2 2
[ P e n t a s ilo x an e , 
d o d e c a m et h yl- , M S9 2R I 1 1 5 2 . 7 ]_ ID 2 _ RI
M Z 2 8 1
1 4 . 2 3 1 1 1 5 3 . 6 2 8 1 0 . 8 3 0 . 6 7 0 . 7 2 0 . 6 6 0 . 9 5 0 . 7 2 0 . 7 9 0 . 6 8 0 . 9 7 0 . 7 7 0 . 4 4 0 . 6 8 1 0 . 4 7 0 . 5 9 0 . 5 0 . 4 8 0 . 6 0 . 5 1 0 . 5 9 0 . 5 0 . 5 5 0 . 6 4 0 . 4 6 0 . 5 5 0 . 5 9 0 . 6
[ B u t a n o ic  a cid ,  2-o xo
b is ( t r im e th y lsily l)  dM S 6 3 ,  
R I 1 1 9 2 . 8 ]_ ID 27 _ RI
M Z 1 4 7
1 5 . 1 4 7 1 1 9 3 . 2 1 4 7 0 . 7 4 0 . 2 7 0 . 2 4 0 . 2 1 0 . 4 1 0 . 2 5 0 . 5 3 0 . 4 4 1 0 . 6 0 . 3 5 0 . 9 1 0 . 7 1 0 . 3 8 0 . 2 2 0 . 4 0 . 1 7 0 . 2 9 0 . 2 1 0 . 5 8 0 . 2 1 0 . 0 4 0 . 1 7 0 . 1 8 0 . 3 0 . 4 4 0 . 2 7
n -
d o d e c a n e _ ID 2 9_ RM Z 4 1
1 5 . 3 0 5 1 2 0 0 4 1 0 . 5 6 0 . 4 1 0 . 4 3 0 . 4 6 0 . 5 5 0 . 4 8 0 . 5 1 0 . 4 3 1 0 . 7 4 0 . 4 6 0 . 6 9 0 . 6 1 0 . 4 7 0 . 5 7 0 . 5 5 0 . 4 8 0 . 5 6 0 . 6 0 . 4 9 0 . 5 2 0 . 5 1 0 . 4 7 0 . 6 7 0 . 5 3 0 . 5 5 0 . 4 8
n -
d o d e c a n e _ ID 2 9_ RM Z 5 7
1 5 . 3 0 6 1 2 0 0 5 7 0 . 5 8 0 . 4 2 0 . 4 3 0 . 4 7 0 . 5 7 0 . 4 9 0 . 5 2 0 . 4 3 1 0 . 7 4 0 . 4 7 0 . 6 9 0 . 6 4 0 . 4 9 0 . 5 9 0 . 5 7 0 . 4 9 0 . 5 8 0 . 6 1 0 . 5 1 0 . 5 4 0 . 5 1 0 . 4 8 0 . 6 7 0 . 5 6 0 . 5 7 0 . 4 9
n -
d o d e c a n e _ ID 2 9_ RM Z 7 1
1 5 . 3 0 6 1 2 0 0 7 1 0 . 5 8 0 . 4 2 0 . 4 4 0 . 4 8 0 . 5 7 0 . 4 9 0 . 5 3 0 . 4 4 1 0 . 7 5 0 . 4 8 0 . 7 0 . 6 4 0 . 4 9 0 . 5 9 0 . 5 8 0 . 4 9 0 . 5 9 0 . 6 2 0 . 5 2 0 . 5 4 0 . 5 2 0 . 4 9 0 . 6 6 0 . 5 6 0 . 5 7 0 . 5
L - V a lin e  
( 2 T M S ) _I D 35 _ RI 12 1Z 1 4 4
1 5 . 5 6 5 1 2 1 1 . 2 1 4 4 0 . 5 0 . 7 6 0 . 2 3 0 . 2 9 0 . 3 7 0 . 1 5 0 . 3 3 0 . 2 9 1 0 . 4 7 0 . 1 6 0 . 4 9 0 . 2 6 0 . 1 4 0 . 0 1 0 . 3 1 0 . 0 2 0 . 0 7 0 . 0 9 0 . 2 5 0 . 1 7 0 . 0 2 0 . 0 6 0 . 0 8 0 . 1 9 0 . 1 2 0 . 0 6
[ U n k n o w n ,  
R I 1 2 1 7 . 2 ]_ ID 36 _ RIM Z 1 4 7
1 5 . 7 3 1 1 2 1 8 . 3 1 4 7 0 . 3 5 0 . 4 4 0 . 3 0 . 3 4 0 . 2 6 0 . 3 3 0 . 2 7 0 . 4 0 . 3 4 0 . 3 5 0 . 3 8 0 . 4 4 0 . 5 9 0 . 2 4 0 . 5 5 0 . 3 5 0 . 3 8 0 . 4 1 0 . 4 1 0 . 7 1 0 . 4 6 1 0 . 5 7 0 . 2 2 0 . 4 5 0 . 4 9 0 . 4 7
[ G ly c in e ,  N- a ce ty l- , 
t r im e t h y ls ily l e s teM S 7 1 ,  
R I 1 2 2 7 . 5 ]_ ID 37 _ RI
M Z 1 7 4
1 5 . 9 4 6 1 2 2 7 . 5 1 7 4 0 . 1 7 0 . 0 9 0 . 1 1 0 . 0 5 0 . 1 0 . 0 6 0 . 1 0 . 0 8 0 . 3 3 0 . 1 6 0 . 3 8 0 . 2 9 0 . 3 6 0 . 5 0 . 2 3 0 . 9 6 0 . 4 6 0 . 2 0 . 6 3 0 . 7 3 1 0 . 3 9 0 . 8 0 . 3 8 1 0 . 6 8 0 . 2 3
[ U n k n o w n ,  
R I 1 2 3 1 . 2 ]_ ID 38 _ RIM Z 2 3 4
1 6 . 0 6 6 1 2 3 2 . 7 2 3 4 0 . 5 0 . 1 2 0 . 2 3 0 . 1 7 0 . 5 7 0 . 3 3 0 . 3 4 0 . 5 9 0 . 3 5 0 . 4 6 0 . 1 6 0 . 3 2 1 0 . 1 7 0 . 3 7 0 . 2 0 . 2 0 . 3 3 0 . 1 1 0 . 2 4 0 . 1 3 0 . 1 4 0 . 2 3 0 . 1 4 0 . 1 8 0 . 2 0 . 3 5
[ G a m m a- hy d ro xy b ut y
a c id  ( 2 T M S ),  M S 89R I 1 2 3 6 . 5 , P u ta v e
U n c o n ﬁ r m e d ]_ ID
6 . 5 _ M Z 1 47
1 6 . 1 7 2 1 2 3 7 . 3 1 4 7 0 . 5 3 0 . 2 8 0 . 3 7 0 . 4 1 0 . 5 7 0 . 4 4 0 . 4 6 0 . 6 3 0 . 6 4 0 . 5 0 . 5 0 . 7 6 1 0 . 4 9 0 . 4 3 0 . 4 0 . 5 4 0 . 5 8 0 . 4 0 . 8 3 0 . 5 6 0 . 2 2 0 . 5 0 . 2 7 0 . 4 5 0 . 7 5 0 . 6
B e n z o ic  a c id  
( 1 T M S ) _I D 41 _ RI 12 5Z 1 7 9
1 6 . 5 4 4 1 2 5 3 . 4 1 7 9 0 . 5 7 0 . 4 5 0 . 3 9 0 . 4 0 . 5 3 0 . 4 4 0 . 4 8 0 . 4 3 1 0 . 7 1 0 . 4 9 0 . 7 4 0 . 5 8 0 . 4 4 0 . 5 3 0 . 5 0 . 5 3 0 . 5 8 0 . 5 2 0 . 5 0 . 4 7 0 . 3 0 . 5 0 . 7 2 0 . 4 9 0 . 5 4 0 . 4 9
L - S e r in e  
( 2 T M S ) _I D 42 _ RI 12 5Z 1 3 2
1 6 . 6 9 3 1 2 5 9 . 8 1 3 2 0 . 2 2 0 . 0 2 0 . 0 1 0 . 0 1 0 . 0 8 0 . 0 2 0 . 1 2 0 . 0 4 0 . 5 4 0 . 2 4 0 . 1 3 1 0 . 6 0 . 1 4 0 0 . 3 2 0 0 . 0 2 0 . 0 3 0 . 2 2 0 . 1 3 0 0 . 0 1 0 . 0 4 0 . 1 7 0 . 3 7 0 . 1 7
L - S e r in e  
( 2 T M S ) _I D 4 _ RI 12 6Z 1 3 2
1 6 . 6 9 5 1 2 5 9 . 9 1 3 2 0 . 2 2 0 . 0 2 0 . 0 1 0 . 0 1 0 . 0 8 0 . 0 2 0 . 1 2 0 . 0 4 0 . 5 4 0 . 2 4 0 . 1 3 1 0 . 6 0 . 1 4 0 0 . 3 2 0 0 . 0 2 0 . 0 3 0 . 2 2 0 . 1 3 0 0 . 0 1 0 . 0 4 0 . 1 7 0 . 3 7 0 . 1 7
[ E t h a n o la m in e  (3 T
M S 9 0 ,  R I 12 6 5. 4,  Pb u t  
U n c o n ﬁ r m e d ]_ ID
5 . 4 _ M Z 1 74
1 6 . 8 2 1 2 6 5 . 3 1 7 4 1 0 . 2 8 0 . 4 4 0 . 1 6 0 . 3 7 0 . 4 5 0 . 3 7 0 . 4 7 0 . 8 9 0 . 6 7 0 . 0 5 0 . 1 8 0 . 1 8 0 . 1 4 0 . 1 3 0 . 0 8 0 . 0 7 0 . 1 4 0 . 1 1 0 . 2 8 0 . 0 5 0 . 0 1 0 . 1 8 0 . 3 2 0 . 1 0 . 0 7 0 . 2 5
Data Matrix
(Tab-delimited/HTML)
[ G e n o t y p e  xE n v ir on m e nt ] C o m pa r iso n : a o x 1 a - 1  ( Le a f) *  N o r m alG r o w th  /  C ol- 0  (L ea f)  *  N o rm a lG ro w t h ( D elt a  R u n T im e:  6 .6  h a o x 1 a - 1  ( Le a f) *  M od _ D ro ug h t_ H ig h_ L ig ht  /  C ol- 0  (L ea f)  *  M o d _D r ou g ht _H ig h _ Lig h
( D e lt a  R u n  T im e : - 3. 6 h )
a o x 1 a - 2  ( Le a f) *  M od _ D ro ug h t_ H ig h_ L ig ht  /  C ol- 0  (L ea f)  *  M o d _D r ou g ht _H ig h _ Lig h  
( D e lt a  R u n  T im e : 2 .1  h )
A n a ly t e  C la s s A n a ly t e  S ig n a l A n n o t a o n A v e r a g e  R e t en  o n T im e ( m in ) A v e r a g e  R e t en  o n I n de x ( K ov a ts ) Q u a n  ﬁ e r  m /z S ig n a l I n t e n s it y R a  o  p - v a l S ig n a l I n t e n s it y R a  o  p - v a l S ig n a l I n t e n s it y R a  o  p - v a l 
U n k n o w n
[ g a m m a- To co p he r ol ( 1 T M S) , M S9 5 , 
R I 3 0 0 0 . 9 , P u ta v e  b u t 
U n c o n ﬁ r m e d ]_ ID 3 35 _ RI 30 0 0. 9_ M Z 48 8
4 4 . 4 1 5 3 0 0 1 . 6 4 8 8 2 . 3 3 0 . 1 3 2 8 2 9 . 0 3 0 . 0 5 0 5 4 . 3 5 0 . 0 4 1 1 1
C a r b o h y d r at es D - ( + ) - Ce lo b io s e m et ho x im e  (8 T M S)  E Z 
P e a k  1 _ I D 2 9 8_ R I2 68 4 .5 _M Z3 6 1
4 0 . 7 2 8 2 6 8 5 3 6 1 1 . 8 9 0 . 1 9 2 9 8 1 . 2 3 0 . 2 2 9 6 3 0 . 9 1 0 . 5 5 1 6 5
U n k n o w n
[ a lp h a - T o co p he r ol ( T M S ), M S 90 , R I 31 4 3.
P u t a  v e  b u t  
U n c o n ﬁ r m e d ]_ ID 3 39 _ RI 31 4 3. 7_ M Z 50 2
4 5 . 9 5 2 3 1 4 3 5 0 2 1 . 8 3 0 . 0 8 0 8 7 1 . 8 2 0 . 2 2 2 1 0 . 6 0 . 0 7 2 8
U n k n o w n
[ 2 - K e t o -l glu c o nic  a c id , p e nt a( O -
t r im e t h y ls ily l) -, M S8 6 , 
R I 1 7 7 4 . 2 ]_ ID 18 9 _R I1 7 74 .2 _ M Z 29 2
2 7 . 3 9 4 1 7 7 5 . 4 2 9 2 1 . 7 7 0 . 0 9 2 4 4 4 . 8 3 0 . 0 0 0 6 2 0 . 7 1 0 . 0 2 8 0 4
U n k n o w n [ U n k n o w n ,  
R I 1 2 1 7 . 2 ]_ ID 36 _ RI 12 1 7. 2_ M Z 1 47
1 5 . 7 3 1 1 2 1 8 . 3 1 4 7 1 . 5 4 0 . 0 8 7 6 0 . 7 5 0 . 0 7 1 0 2 0 . 8 5 0 . 2 4 6
U n k n o w n [ U n k n o w n  D is a c ch ar id e , 
R I 2 5 4 4 . 4 ]_ ID 29 1 _R I2 5 4 .4 _ M Z 36 1
3 8 . 9 2 5 2 5 4 6 . 3 3 6 1 1 . 5 1 0 . 1 3 9 9 1 0 . 7 5 0 . 1 2 8 1 3 0 . 7 5 0 . 1 2 3 2 9
U n k n o w n [ C a m p e st e ro l ( 1T M S ),  M S 95 , P u t a v e b u
U n c o n ﬁ r m e d ]_ ID 3 42 _ RI 32 6 4. 6_ M Z 34 3
4 7 . 2 4 7 3 2 6 5 . 6 3 4 3 1 . 4 6 0 . 1 6 6 0 4 1 . 0 9 0 . 6 8 6 0 8 0 . 4 8 0 . 0 0 7 3 2
U n k n o w n [ U n k n o w n ,  
R I 3 3 6 3 . 0 ]_ ID 34 7 _R I3 3 63 _ M Z 38 6
4 8 . 2 6 3 3 6 3 . 8 3 8 6 1 . 3 8 0 . 2 2 8 2 2 2 . 2 7 0 . 0 2 1 1 3 1 . 0 1 0 . 9 7 7 0 6
U n k n o w n
[ b e t a - S it os te ro l t r im e th y lsiy l e t h e r,  
M S 8 6 ,  P u t a v e b u t  
U n c o n ﬁ r m e d ]_ ID 3 46 _ RI 3 4 9. 4_ M Z 35 7
4 8 . 1 0 8 3 3 4 9 . 1 3 5 7 1 . 3 7 0 . 3 0 1 8 4 1 . 0 7 0 . 7 7 0 7 0 . 4 6 0 . 0 0 0 8 7
U n k n o w n
[ P e r - O - tr im e th yls ily l- ( 3- O- d-
m a n n o p y ra n os y l-4 -O -d -g lu c op y ra no s yl- d
g lu c it o l) ,  M S 72 , 
R I 2 8 0 8 . 4 ]_ ID 31 8 _R I2 8 08 .4 _ M Z 45 1
4 2 . 2 9 7 2 8 0 6 . 5 4 5 1 1 . 3 6 0 . 1 6 6 4 3 0 . 6 4 0 . 0 3 2 6 5 0 . 4 8 0 . 0 0 7 8 4
U n k n o w n
[ S ila n e ,  [ [ (3 ,2 4 R) -e rg os t- 5- en -3 -
y l] o x y ] t rim et h yl- , 
M S 8 8 ] _ ID 3 4 3_ R I3 26 7 .1 _M Z 4 72
4 7 . 2 4 9 3 2 6 5 . 9 4 7 2 1 . 3 4 0 . 2 0 2 1 9 1 . 0 9 0 . 7 0 1 2 9 0 . 4 9 0 . 0 0 6 1
U n k n o w n
[ I n o s it o l m on o ph o sp ha t e,  M S 94 , R I 24 0 7.
P u t a  v e  b u t  
U n c o n ﬁ r m e d ]_ ID 2 80 _ RI 24 0 7. 7_ M Z 31 8
3 7 . 1 2 5 2 4 0 8 . 1 3 1 8 1 . 3 3 0 . 5 3 4 6 1 . 2 5 0 . 5 4 7 9 1 . 3 1 0 . 3 4 1 1
A lc o h o ls  a n d  P o ly o ls M a n n it o l ( 6 T M S )_ ID 2 23 _ RI 19 1 1. 8_ M Z 31 2 9 . 9 0 6 1 9 1 2 . 1 3 1 9 1 . 2 9 0 . 5 0 7 8 2 2 . 0 6 0 . 0 0 1 2 . 3 7 0 . 0 0 0 1 8
U n k n o w n [ G ly c in e ,  N - a ce ty l- , t rim et h yls ily l e s t er , 
M S 7 1 ,  R I 12 2 7. 5] _I D 37 _ RI 12 2 7. 5_ M Z 17 4
1 5 . 9 4 6 1 2 2 7 . 5 1 7 4 1 . 2 4 0 . 4 5 6 4 9 0 . 2 8 0 . 0 0 2 1 0 . 3 5 0 . 0 0 2 2 2
A m in o  A c id s L - A la n in e  ( 3 T M S )_ ID 6 6_ R I1 36 0 .8 _M Z 1 1 9 . 0 3 6 1 3 6 1 1 8 8 1 . 2 3 0 . 6 4 4 3 4 0 . 2 0 . 0 2 8 9 3 0 . 2 2 0 . 0 3 3 7 9
A m in o  A c id s L - A la n in e  ( 3 T M S )_ ID 6 6_ R I1 36 0 .8 _M Z 2 1 9 . 0 3 6 1 3 6 0 . 9 2 6 2 1 . 2 3 0 . 6 5 1 4 0 . 1 8 0 . 0 3 5 4 4 0 . 2 1 0 . 0 4 1 6 1
U n k n o w n [ C y c lo p e n t as ilo x an e , d e ca m et h yl- , M S9 1
R I 1 1 1 6 . 2 ]_ ID 19 _ RI 1 1 6. 2_ M Z 3 5
1 3 . 3 9 5 1 1 1 7 . 3 3 5 5 1 . 2 0 . 1 3 2 9 9 0 . 4 0 . 0 0 2 3 4 1 . 1 2 0 . 5 7 1 7
U n k n o w n [ U n k n o w n  S u g ar , 
R I 2 3 8 9 . 1 ]_ ID 27 7 _R I2 3 89 .1 _ M Z 20 4
3 6 . 8 8 8 2 3 9 0 2 0 4 1 . 1 9 0 . 4 5 8 0 2 1 . 3 8 0 . 2 7 8 4 1 0 . 9 3 0 . 6 2 6 3 9
U n k n o w n [ U n k n o w n ,  
R I 3 1 6 4 . 7 ]_ ID 34 0 _R I3 1 64 .7 _ M Z 20 7
4 6 . 2 0 1 3 1 6 5 . 9 2 0 7 1 . 1 7 0 . 2 8 9 6 8 0 . 7 2 0 . 1 2 0 5 3 0 . 5 5 0 . 0 4 5 1 8
D ic a r b o x y lic  A c id s C it r a m a lic  a c id  
( 3 T M S ) _I D 97 _ RI 14 6 6. 4_ M Z 24 7
2 1 . 4 7 8 1 4 6 6 . 4 2 4 7 1 . 1 7 0 . 4 7 3 9 0 . 5 4 0 . 0 5 6 4 8 0 . 4 3 0 . 0 2 8 9
U n k n o w n
[ P h o s p h o ric  a c id , 
b is ( t r im e th y lsiy l) m o n om e t hy l e s te r,  
M S 9 1 ,  R I 1 7 0. 6,  P ut a v e  b ut  
U n c o n ﬁ r m e d ]_ ID 2 5_ R I1 17 0 .6 _M Z 2 41
1 4 . 6 6 1 1 1 7 2 2 4 1 1 . 1 7 0 . 7 0 2 0 1 0 . 4 5 0 . 1 3 9 7 3 0 . 2 1 0 . 0 5 3 3 8
C a r b o h y d r at es D - ( + ) - Ce lo b io s e m et ho x im e  (8 T M S)  E Z 
P e a k  2 _ I D 2 9 9_ R I2 71 4 _M Z3 6 1
4 1 . 0 9 6 2 7 1 3 . 2 3 6 1 1 . 1 6 0 . 3 9 8 5 9 1 . 3 3 0 . 1 7 0 8 7 1 . 3 5 0 . 1 0 2 0 6
U n k n o w n
[ 9 , 1 2 - O ct ad e ca d ie no ic  a cid  ( Z ,Z )-,  
t r im e t h y ls ily l e s te r,  M S 9 2,  
R I 2 2 0 8 . 2 ]_ ID 26 1 _R I2 2 08 .2 _ M Z 3 7
3 4 . 5 2 3 2 2 0 8 . 4 3 3 7 1 . 1 6 0 . 6 7 9 8 3 0 . 8 3 0 . 5 0 7 7 3 0 . 3 4 0 . 0 0 2 8 2
U n k n o w n
[ D - M a n n op y ra no s id e,  m e th yl 2 , 3 ,4 ,6 -
t e t r a k is - O- (t rim e t hy ls ily l) -, M S 80 , 
R I 1 8 4 4 . 6 ]_ ID 20 6 _R I1 8 4 .6 _ M Z 20 4
2 8 . 6 9 7 1 8 4 5 . 4 2 0 4 1 . 1 5 0 . 5 8 9 9 8 0 . 7 6 0 . 1 3 8 8 9 0 . 7 2 0 . 1 0 3 6 7
U n k n o w n [ U n k n o w n ,  
R I 2 5 7 3 . 6 ]_ ID 29 4 _R I2 5 73 .6 _ M Z 18 9
3 9 . 2 8 2 2 5 7 3 . 8 1 8 9 1 . 1 4 0 . 6 7 8 9 0 . 9 0 . 6 8 5 9 4 0 . 6 4 0 . 1 8 3 5 8
U n k n o w n [ U n k n o w n ,  
R I 2 5 6 7 . 4 ]_ ID 29 3 _R I2 5 67 .4 _ M Z 18 9
3 9 . 1 9 9 2 5 6 7 . 5 1 8 9 1 . 1 3 0 . 6 8 7 2 0 . 8 7 0 . 6 0 0 7 8 0 . 6 4 0 . 1 7 6 9 7
U n k n o w n [ U n k n o w n  P u t a v e S ilo x a n e A r te fa c t, 
R I 1 3 0 0 . 9 ]_ ID 54 _ RI 13 0 0. 9_ M Z 4 29
1 7 . 6 6 8 1 3 0 2 4 2 9 1 . 1 3 0 . 5 1 0 8 8 0 . 3 0 . 0 0 2 9 2 1 . 1 8 0 . 5 0 9 5 3
A lc o h o ls  a n d  P o ly o ls G ly c e r o l ( 3 T M S) _I D4 6 _R I1 2 71 .6 _ M Z 20 5 1 7 . 0 1 2 1 2 7 3 . 5 2 0 5 1 . 1 2 0 . 3 9 8 6 5 0 . 9 1 0 . 3 3 0 6 6 0 . 7 3 0 . 0 3 7 4
A lc o h o ls  a n d  P o ly o ls G ly c e r o l ( 3 T M S) _I D4 6 _R I1 2 71 .6 _ M Z 21 8 1 7 . 0 1 3 1 2 7 3 . 5 2 1 8 1 . 1 2 0 . 3 8 9 1 3 0 . 9 1 0 . 3 2 6 9 2 0 . 7 3 0 . 0 4 1 5 6
C a r b o h y d r at es D - ( - ) -A r ab in o se  m e th o xim e 
( 4 T M S ) _I D 16 1 _R I1 6 59 .6 _ M Z3 0 7
2 5 . 2 4 6 1 6 6 0 . 3 3 0 7 1 . 1 1 0 . 3 5 5 3 7 1 . 0 3 0 . 6 9 5 7 5 1 . 0 7 0 . 3 4 2 5 5
U n k n o w n [ O le ic  a c id ,  t r im e t hy ls ily l e s te r , M S 8 9,
R I 2 2 1 4 . 4 ]_ ID 26 3 _R I2 2 14 .4 _ M Z 3 9
3 4 . 6 2 2 1 4 . 2 3 3 9 1 . 1 0 . 7 5 8 4 1 0 . 7 7 0 . 2 5 7 7 3 0 . 3 7 0 . 0 0 1 0 2
U n k n o w n [ S e d o h e p tu lo s e m et ho x im e  (6 T M S) , M S8 6
R I 2 1 1 6 . 9 ]_ ID 25 2 _R I2 1 16 .9 _ M Z 31 9
3 3 . 1 1 3 2 1 1 6 . 9 3 1 9 1 . 0 9 0 . 5 6 6 1 6 1 . 4 5 0 . 1 0 9 9 3 1 . 5 9 0 . 0 1 7 8 9
Intensity ratio/t-test
(Tab-delimited/HTML)
PC1 (53.85% of Total Variance)
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::::G x E Style Legend::::
Col-0 (Leaf) * Mod_Drought_High_Light
130707_WT HL DROUGHT_2
130707_WT HL DROUGHT_3
130707_WT HL DROUGHT_4
130707_WT HL DROUGHT_5
Col-0 (Leaf) * NormalGrowth
130707_WT UNTREATED_1
130707_WT UNTREATED_2
130707_WT UNTREATED_3
130707_WT UNTREATED_5
PCA
(Tab-delimited/HTML/SVG/X3D)
HCA
(PDF)
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130707_WT UNTREATED_3.PEAKLIST
130707_WT UNTREATED_2.PEAKLIST
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Correlation Analysis
(PDF)
Metadata
(Tab-delimited)
[ G e n o t y p e  xE n v ir on m e nt ] C o m pa r iso n : a o x 1 a - 1  ( Le a f) *  N o r m alG r o w th  /  C ol- 0  (L ea f)  *  N o rm a lG ro w t h ( D elt a  R u n T im e:  6 .6  h a o x 1 a - 1  ( Le a f) *  M od _ D ro ug h t_ H ig h_ L ig ht  /  C ol- 0  (L ea f)  *  M o d _D r ou g ht _H ig h _ Lig h
( D e lt a  R u n  T im e : - 3. 6 h )
a o x 1 a - 2  ( Le a f) *  M od _ D ro ug h t_ H ig h_ L ig ht  /  C ol- 0  (L ea f)  *  M o d _D r ou g ht _H ig h _ Lig h  
( D e lt a  R u n  T im e : 2 .1  h )
A n a ly t e  C la s s A n a ly t e  S ig n a l A n n o t a o n A v e r a g e  R e t en  o n T im e ( m in ) A v e r a g e  R e t en  o n I n de x ( K ov a ts ) Q u a n  ﬁ e r  m /z S ig n a l I n t e n s it y R a  o  p - v a l S ig n a l I n t e n s it y R a  o  p - v a l S ig n a l I n t e n s it y R a  o  p - v a l 
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Page 6 of 13retention times yielded an R2 of 1.0000 while regression of
integrated peak areas gave an R2 of 0.997 indicating excel-
lent correlation between the two algorithms. Detailed
tables of integration results and regression analyses are
presented in additional file 3.
Mass-spectral and retention-index (MSRI) library matching 
and quantification
Any detailed biological interpretation of a GC/MS
metabolomics data set requires that signals correspond-
ing to analytes of biological origin are correctly identified
and distinguished from those corresponding to artefacts
or internal standard compounds. Compliance with
Metabolomics Standards Initiative (MSI) standards for
metabolite identification requires that at least two
orthogonal analytical parameters are used to match ana-
lytical signals to particular metabolites [26]. For this pur-
pose, MetabolomeExpress uses two widely-accepted
identification parameters: retention index (RI) and mass
spectrum.
The MetabolomeExpress MSRI library matching algo-
rithm accepts EIC peak lists (as generated by the Peak-
Finder algorithm), a mass-spectral and retention index
(MSRI) GC/MS reference library (a table of retention
indices, mass spectra and quantifier ion information for
authentic standards and unknown analytes observed in
biological samples) and a simple RI calibration file (a
table of retention times and retention indices for an array
of RI standards such as n-alkanes) as input and generates
a match report file as output. A number of matching cri-
teria may be set.
The library matching process employed by the algo-
rithm is detailed in the MetabolomeExpress User's Guide
(additional file 1). Briefly, EIC peaks are grouped (on the
basis of their apex RIs) into 0.1 RI unit bins which may
then be considered as 'preliminary spectra'. A library
search is then performed on each RI bin. Each library
search begins by searching the supplied MSRI library for
entries with RIs within a specified RI tolerance window of
the query bin's RI. If a library entry with an RI match is
thus identified, the bin spectrum is searched for each
analyte-specific quantifier ion specified for in the library
entry. If no such quantifier ion is found, the match
attempt is aborted. However, if a quantifier ion is found,
the intensity of that ion and the library spectrum are used
to predict the expected intensities of qualifier ions that
should be present in the observed spectrum. Since these
may apex at slightly different times than the quantifier ion
due to subtle differences in signal shape, EIC peaks within
a small user-definable RI window of the quantifier ion are
at this point gathered from the total peak list and added
to the RI bin being queried. If enough qualifier ions with
the expected intensities are found and the average devia-
tion of all potential qualifier ions from expected intensi-
ties is below a set threshold, the match is passed and the
peak area of the quantifier reported as the signal intensity
for the matched analyte.
The algorithm supports both internal and external RI
calibration and quantification based on multiple library-
specified analyte-specific quantifier ions (a separate
match attempt is made for each quantifier ion). Users
may provide their own reference library or use one of the
public libraries provided by MetabolomeExpress or one
of its members. The MetabolomeExpress MSRI library
format is a simple tab-delimited structure that should be
easy to generate from other formats. Alternatively, librar-
ies may be constructed in AMDIS format (*.MSL) using
the freely available AMDIS software package http://
chemdata.nist.gov/mass-spc/amdis/ and then converted
to MetabolomeExpress format using the MSRI Library
Manager tool that is part of Database Explorer. MSRI
Library Manager also provides a facility to check whether
the names of library entries are recognised by the Metab-
olomeExpress metabolite name recognition system.
Comparison of MetabolomeExpress- and AMDIS-based 
MSRI library matching
The Automated Mass-spectral Deconvolution and Identi-
fication System (AMDIS) software package http://chem-
data.nist.gov/mass-spc/amdis/ is widely regarded as one
of the best freely available qualitative analysis tools for
the deconvolution of complex GC/MS datasets and
matching of GC/MS signals to reference libraries on the
basis of mass spectra and retention indices. Notable
metabolomics applications of AMDIS include creation
and implementation of the popular Golm Metabolome
Database 'Q_MSRI_ID' GC-Quadrupole-MS MSRI
library [27] (freely available at http://csbdb.mpimp-
golm.mpg.de) and integration with quantitative data pro-
cessing tools such as the freely available MET-IDEA [9]
and the proprietary Deconvolution and Reporting Soft-
ware (DRS; Agilent Technologies; http://www.chem.agi-
lent.com) to create metabolomics data processing
workflows capable of both identification and quantifica-
tion of metabolite signals in complex GC/MS metabolo-
mics datasets.
To demonstrate the effectiveness of the Metabolome-
Express MSRI library matching workflow, we used
AMDIS and MetabolomeExpress in parallel to identify
metabolite signals in a representative GC/MS chromato-
gram produced by analysis of a typical complex biological
extract (a crude methanolic extract of an Arabidopsis
plant cell suspension culture) using the same MSRI
library and compared the results (detailed in additional
file 4; summarised in Table 1). For AMDIS processing, we
used the same deconvolution settings as those used to
generate the GMD 'Q_MSRI_ID' library [27] including
two different adjustments of the AMDIS 'Sensitivity' set-
Carroll et al. BMC Bioinformatics 2010, 11:376
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Page 7 of 13ting ('low' and 'high'). Full details on AMDIS settings used
are provided in additional file 4. For MetabolomeExpress
processing, we also conducted two searches - one with
default settings and one with the 'Min. Peak Area' setting
adjusted from the default of 25,000 to 5,000 which will be
referred to as 'low-sensitivity' (LS) and 'high-sensitivity'
(HS) settings, respectively. This setting determines the
minimum area value an EIC peak must have to be
imported from the submitted peak list for RI-binning and
library matching. Similarly to having a higher AMDIS
'Sensitivity' setting, having a lower 'Min. Peak Area' set-
ting in MetabolomeExpress enables smaller peaks to be
identified but increases the chances of false-positive
detections or quantification based on small, noisy peaks
which may give inaccurate results.
After running all four searches, we aligned all the peak
identification results in MS Excel before manually vali-
dating each call of analyte presence or absence by inspec-
tion of relevant raw GC/MS signals. The results of these
manual validations, including justifications for our con-
clusions where any ambiguity between AMDIS and
MetabolomeExpress results was apparent, are presented
in additional file 4. In many cases where we observed
false negative detections, we explain why these occurred.
Based on our validations, we then classified each pres-
ence/absence call as a true positive, false positive, ambig-
uous positive, true negative, false negative or ambiguous
negative. These results are summarised in Table 1.
Overall, the results from AMDIS and MetabolomeEx-
press were very similar with 141 (72%) of the total set of
197 peak identifications being reported by both pro-
grams. However, MetabolomeExpress outperformed
AMDIS in all regards by reporting more true positives,
fewer false/ambiguous positives and fewer false/ambigu-
ous negatives (Table 1). This was particularly pronounced
under HS settings where MetabolomeExpress gave 163
true positives compared to the 150 reported by AMDIS.
However, the biggest strength of MetabolomeExpress rel-
ative to AMDIS was its lower false reporting rate. Under
HS settings, AMDIS and MetabolomeExpress reported
15 and 7 false/ambiguous positives; and 26 and 8 false/
ambiguous negatives, respectively (Table 1).
A common data-processing approach employed by
metabolomics researchers is to use AMDIS-based peak
deconvolution and identification to assist creation of tar-
get compound quantification libraries for specific quanti-
fier ion-based quantification in their GC/MS
manufacturer's proprietary data-analysis software (eg.
Agilent's ChemStation). To demonstrate that the Metab-
olomeExpress workflow can achieve results of at least the
same level of quality, we used the results generated in the
above analysis to build an RT and quantifier ion-based
ChemStation compound quantitation library for the 80
identified compounds of known structure and quantita-
tively processed the representative plant cell extract data
file using ChemStation with an optimised sensitivity set-
ting. Linear regression of ChemStation- and Metabolom-
eExpress-reported RTs and peak areas for the 78 target
peaks successfully integrated by ChemStation (using the
MetabolomeExpress values generated previously under
HS settings, above) gave near perfect R2 values of 1.0000
and 0.998, respectively. This demonstrates that the
MetabolomeExpress workflow not only gives excellent
qualitative performance, but quantitative performance as
well. Moreover, construction of the RT-based quantita-
tion library in ChemStation was a relatively laborious
Table 1: Comparison of AMDIS and MetabolomeExpress MSRI library matching performance: summary of results.
AMDIS MetabolomeExpress
Settings: Low Sensitivity High Sensitivity Low Sensitivity High Sensitivity
Total Peak Identifications Reported 152 165 153 170
True Positive 140 150 149 163
False Positive 7 12 0 1
False Negative 35 24 20 7
Ambiguous 5 5 6 7
A raw data file from a representative GC/MS analysis of a complex methanolic plant tissue extract was processed and searched against a single 
MSRI reference library using either AMDIS or MetabolomeExpress. Each software package was used under two different sensitivity settings to 
allow a more meaningful comparison of results. All peak identification results were manually verified by inspection of relevant raw GC/MS signals 
as true positives, false positives, false negatives or ambiguous calls. False negatives were cases where a search failed to identify a component that 
was successfully identified by another search. Detailed results including manual validation comments are presented in additional file 4.
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Page 8 of 13process that requires manual pre-definition of a limited
number of qualifier ions via the ChemStation interface
rather than dynamic selection of an unlimited number of
qualifier ions based on deconvoluted library spectra that
are easily manageable within tab-delimited files. Further-
more, unlike the RI-based approach of MetabolomeEx-
press, ChemStation-based quantitation would require
either: a) regular re-adjustment of target RT settings to
account for changes in RT associated with drift or col-
umn maintenance; or b) regular time-consuming 'reten-
tion time locking' of the instrument by fine tuning of
carrier gas flow rates based on flow:RT calibration runs.
Quantitative validation of the MetabolomeExpress data 
processing workflow
In order to further quantitatively validate the Metabo-
lomeExpress data processing workflow, we generated a
challenging dataset through the GC/MS analysis of a set
of complex standard mixtures carefully designed to intro-
duce large known variations in the relative concentra-
tions of co-eluting analytes and hence the relative
intensities of overlapping or closely neighbouring signals.
The procedure used to prepare these complex mixtures is
detailed in Figure 3. Essentially, three simple mixtures
each containing a unique set of 20-30 chromatographi-
cally resolved analytes were repeatedly combined in
widely varying concentration ratios to generate a set of
complex mixtures (each containing ~90 metabolites) in
which co-elution of differentially diluted analytes would
occur during GC/MS analysis. This dataset was chosen
(as opposed to a simple single-mixture dilution series) to
strengthen our validation by increasing the likelihood of
misidentification or quantitative interference between
overlapping or neighbouring signals. The raw dataset
thus generated was processed using the MetabolomeEx-
press data processing pipeline including peak detection,
MSRI library matching and data matrix construction
steps. Data matrix construction included normalisation
to the internal standard, ribitol, and automatic raw data-
assisted missing value replacement whereby each missing
value was replaced with the sum of the relevant EIC sig-
nal between the average integration start and end points
for runs where the analyte with the missing value was
successfully matched (see the MetabolomExpress User's
Guide for details on data matrix construction).
The basic premise of our validation approach was that
if peak integration, library matching and data matrix con-
struction worked correctly (ie. neighbouring signals were
quantitatively resolved and correctly identified), then a
strong relationship between the signal intensity ascribed
to a particular metabolite and the known concentration
of that metabolite should be observed. Therefore, to vali-
date peak integration, library matching and data matrix
construction, we calculated the coefficient of determina-
Figure 3 Validation experiment: randomised combinatorial me-
tabolite standard mixing. Three metabolite mixtures each contained 
a set of approximately 30 different non-co-eluting high-purity authen-
tic metabolite standards at known concentrations (typical metabolite 
concentration: 200 ng/μl). The components of these mixtures were 
chosen such that no chromatographic co-elution would occur be-
tween components of the same mixture but co-elution would occur 
between components of different mixtures when two or more of the 
mixtures were combined into a single analysis. An eight point dilution 
series was prepared from each of the three mixtures, generating three 
sets of eight solutions. The order of each dilution series was ran-
domised to generate a randomised mixing protocol table and aliquots 
of solutions were combined accordingly. This randomised mixing pro-
cess was repeated 5 times to generate 5 sets of 8 solutions (40 solu-
tions). These complex solutions, each containing the same set of 85 
metabolite standards, were analysed by a standard GC/MS metabolo-
mics protocol.
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Page 9 of 13tion (R2) between concentration and reported signal
intensity for 81 metabolite peaks representing a wide
range of retention times and chemical classes (ie. all the
peaks representing the standards in our test mixtures).
Indeed, a strong average concentration:signal intensity R2
value of 0.88 was observed when the best performing
library spectrum and quantifier ion was selected for each
of the 81 metabolite peaks (additional file 5). The best
and worst performing peaks were Xylose methoxime
(4TMS, quantified on m/z = 217; Figure 4A) and Glu-
tamine (3TMS, quantified on m/z = 156; Figure 4B) with
concentration:signal intensity R2 values of 0.995 and
0.404, respectively. R2 values were generally high with 66
(81%) of the 81 metabolite peaks showing an R2 value >
0.8 (see Figure 4C for a histogram).
To determine whether the poor performance of Glu-
tamine (3TMS) was due to some kind of processing error,
we manually inspected the Glutamine (3TMS) signals
and found their sizes were consistent with reported
intensity values. Upon further investigation, we found
that, for samples originally containing the same amount
of glutamine, the observed Glutamine (3TMS) signal was
negatively correlated with the length of time between
derivatisation and GC/MS analysis (Figure 5). This indi-
cated that the high variability in Glutamine (3TMS) sig-
nal that caused the poor concentration:signal intensity
correlation was due to an unknown time-dependent
chemical process causing loss of Glutamine (3TMS) in
samples over time. Interestingly, the signal for the only
detectable Glutamine (4TMS) isomer was stable over the
course of analysis (based on manual inspection of appro-
priate m/z 227 and 317 signals; data not shown) and did
not exhibit a time-dependent increase as would be
expected if the variability in Glutamine (3TMS) were due
to slow derivatisation of the relatively inert amido group
to form the observed Glutamine (4TMS). We could find
no evidence for the presence of Glutamine (5TMS) or any
reports in the literature of this theoretical derivative
being detected by GC/MS. We therefore conclude that
the time-dependent depletion of Glutamine (3TMS) was
due to an unknown chemical process other than slow
derivatisation.
Statistics and exploratory data analysis
The Statistics and Data Exploration panel of the Experi-
ment Explorer module currently provides tools to carry
out data matrix construction, data matrix renormalisa-
tion, data matrix heatmap visualisation, Welch's t-tests,
principal components analysis (PCA) and hierarchical
clustering analysis (HCA). Statistical results are displayed
in the web interface but may also be downloaded for
offline analysis. Colour is used to aid data interpretation
wherever possible. T-test results are presented as a red/
blue heatmap table that allows results to be sorted by
metabolite name, chemical class, retention time, reten-
Figure 4 Validation of the MetabolomeExpress MSRI Library 
Matching algorithm. The challenge dataset described in Figure 3 was 
processed using MetabolomeExpress and the strength of the relation-
ship between metabolite concentration and reported signal intensity 
assessed for each metabolite derivative peak by calculating coeffi-
cients of determination (ie. R2 values). Linear regression plots are 
shown for (A) the best performing peak, Xylose (4TMS) and (B) the 
worst performing peak, Glutamine (3TMS). A histogram (C) shows the 
distribution of R2 values across the 81 metabolite derivative peaks ex-
amined.
Figure 5 Poor 'concentration:signal intensity' correlation for glu-
tamine (3TMS) was due to its time-dependent consumption by an 
unknown chemical process. The graph above shows the relationship 
between Glutamine (3TMS) signal intensity and time of analysis for 5 
derivatised samples each originally supplied with the same amount of 
glutamine (450 pmol/μl). All samples were derivatised at the same 
time so a later time of analysis corresponds to a greater sample age.
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Page 10 of 13tion index, signal intensity ratio or p-value. Wherever
possible, displayed results are linked to their underlying
raw GC/MS signals by point-and-click access - thus aid-
ing manual verification of processed results. PCA plots
are provided in 2D and 3D formats. PCA plots and HCA
heatmap clustergrams are provided in vector formats for
creation of publication quality figures.
To further demonstrate the validity of MetabolomeEx-
press data processing, we performed hierarchical cluster-
ing analysis on the data matrix generated from the
challenge dataset to show that we could resolve three
major clusters of highly correlated metabolites (Figure 6)
that corresponded precisely to the components of each of
the three simple metabolite mixtures combined in differ-
ent ratios to make each analysed complex mixture (see
Figure 3).
The Database Explorer
The Database Explorer module of MetabolomeExpress
provides a number of tools with which to explore the con-
tents of the MetabolomeExpress database of metabolite
signal intensity ratio statistics. The first of these, Data-
base Statistics, provides an overview of the current data-
base contents and buttons to load experiments into the
Experiment Explorer module for more detailed analysis.
The second tool, ResponseFinder, is a simple query tool
that allows users to search for metabolite responses of
interest. Results are returned with links to experimental
metadata and underlying raw GC/MS signals in the raw
data viewer. The third tool is MetaAnalyser. This allows
the results of multiple experiments to be aligned, clus-
tered and compared in heatmap form.
Future developments
Development of the MetabolomeExpress platform will be
an ongoing process. Developments planned for Metabo-
lomeExpress include: i) support for data exchange for-
mats developed or endorsed by the Metabolomics
Standards Initiative and similar initiatives; ii) enhanced
capability for processing LC/MS and CE/MS metabolo-
mic and quantitative proteomic data (including accurate-
mass signals); iii) expansion of the suite of statistical data
mining tools to include multivariate pattern matching
tools to identify relationships between different metabo-
lome response patterns and hence different biological
processes; iv) enhanced facilities for capturing experi-
mental metadata during experimental workflows; v)
increased variety of import/export options for easier inte-
gration with external data processing workflows; vi) sup-
port for integrated analysis of parallel metabolite-, gene-
and protein-expression data; and vii) a capacity to accept
GET requests for information about experiments or sta-
tistical results so that results presented in electronic arti-
cles and other databases may be directly linked to
MetabolomeExpress database content.
Discussion
As GC/MS metabolomics becomes an increasingly main-
stream bio-analytical technique, it is crucial that steps are
taken to ensure published metabolomics data are accessi-
ble, reliable, reusable and transparent. This is largely the
case in the microarray field where journals have enforced
compliance to metadata reporting standards and submis-
sion of raw microarray data to online public repositories.
However, the development of similar repositories for raw
and processed metabolomics datasets is a far greater
challenge due to the sheer size, complexity and heteroge-
neity of these datasets. Precisely for these reasons, it is
essential that online metabolomics databases do not act
merely as warehouses for raw and/or processed datasets
that must be painstakingly downloaded and pieced back
together manually using local desktop programs. Rather,
online metabolomics databases should provide easy, in-
situ access to the various levels of metabolomics datasets
in an integrated, interactive manner. This is the philoso-
phy we have adopted in the development of Metabolome-
Express. For an overview of the features that distinguish
MetabolomeExpress from existing comparable GC/MS
metabolomics web-tools, see Table 2.
Figure 6 Global validation by correlation analysis of a combina-
torial metabolite standard mixing GC/MS data set. The data matrix 
generated by MetabolomeExpress processing of the combinatorial 
standard mixing GC/MS data set (see Figure 3) was filtered to remove 
internal standards and analytes of unknown structure and then used to 
generate a correlation matrix which was used as input for hierarchical 
clustering in the statistical package, R. The reordered correlation matrix 
is shown as a heatmap with colours corresponding to analyte-analyte 
correlation coefficients (see color bar to the right). As expected, ana-
lytes were clustered into three major clusters corresponding to metab-
olite sub-mixes 1, 2 and 3 (see Figure 3). Analyte names have been 
coloured according to their metabolite submixture of origin (Mix 1 = 
red; Mix 2 = green; Mix 3 = blue). * Known breakdown product.
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Page 11 of 13Table 2: Features distinguishing MetabolomeExpress from existing GC/MS metabolomics web-tools.
PlantMetabolomics.org SetupX MeltDB MetaboAnalyst Metabolome
Express
Peer-reviewed biological content
Number of peer-reviewed, biology-focused publication 
datasets publicly available
0* 0 0 0 8
Data upload/storage
Accepts public raw data submissions + +
Accepts public processed data submissions + +
Long-term data storage + + + +
Data resources for download
MSI-compliant metadata + + +
Raw GC/MS data files + +
Mass peak lists + +
Library match lists + +
Data matrices + + +
Mass-spectral and retention-index libraries +
Precomputed fold-change/comparative statistical 
results
+ +
PCA Results + +
HCA Results + +
Statistical heatmap spreadsheets +
Metabolite-metabolite correlation network graphs +
Metabolite-metabolite correlation tables +
MapMan importable fold-change data files +
Cytoscape-importable fold-change data files +
Raw data processing
Provides integrated access to peak detection + + +
Provides own peak detection algorithm +
Performs peak identification without offline pre-
processing
+
Supports upload of custom MSRI libraries +
Statistics
Allows users to perform custom statistical comparisons + + + +
Fold change + + + +
t-test + + +
Principal Components Analysis (PCA) + + +
Cluster Analysis + + +
Metabolite-metabolite correlation Analysis +
Carroll et al. BMC Bioinformatics 2010, 11:376
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MetabolomeExpress https://www.metabolome-express.
org provides a new opportunity for the metabolomics
community to transparently and interactively present
online the raw and processed GC/MS metabolomics data
underlying their research findings. Transparent sharing
of these data has the potential to increase the value of
metabolomics publications by allowing the broader
research community to assess data quality and draw their
own insights from disseminated datasets. Moreover, the
centralised storage and systematic annotation of metabo-
lite response information from diverse biological systems
and experimental perturbations, together with meta-
analysis tools, will reveal previously unrecognised pat-
terns and thus facilitate mechanistic and evolutionary
discoveries that would have otherwise been far more dif-
ficult to make.
Availability and requirements
The MetabolomeExpress web application is freely acces-
sible for non-commercial, academic use at https://www.
metabolome-express.org. Registered users may access the
FTP repository at ftp://www.metabolome-express.org.
The major client hardware and software requirements
to use the MetabolomeExpress web interface and FTP
server are:
• A modern version of one of the major web browsers 
(ie. Microsoft Internet Explorer, Mozilla Firefox, 
Google Chrome or Safari)
• Minimum of 512 MB of RAM (1GB+ recom-
mended)
• A relatively fast internet connection
• A two-button mouse
• An FTP client program (eg. FileZilla; Only required 
if uploading data).
Additional material
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Additional file 1 MetabolomeExpress v1 User's Guide. The current 
MetabolomeExpress user's manual including detailed instructions and 
examples on how to upload and manage datasets via FTP and how to use 
all current features of the MetabolomeExpress web interface.
Additional file 2 Notes on FTP repository and data formats. Detailed 
comments about the MetabolomeExpress FTP repository and data formats 
supported by MetabolomeExpress and rationales behind their designs.
Additional file 3 MetabolomeExpress peak detection validation 
results. Comparison of peak integration results from Agilent ChemStation 
and MetabolomeExpress PeakFinder algorithm. Includes detailed peak 
detection information.
Additional file 4 Comparison of MetabolomeExpress Library Match-
ing with AMDIS and ChemStation. Detailed results of the comparison of 
AMDIS-based analyte signal identification (and subsequent ChemStation-
based quantitation) with the integrated identification and quantitation 
approach of MetabolomeExpress (described in the section entitled 'Com-
parison of MetabolomeExpress- and AMDIS-based MSRI library matching' 
with results summarised in Table 1).
Additional file 5 MetabolomeExpress validation - standard curves. 
The data matrix obtained by MetabolomeExpress processing of the dataset 
described in Figure 3. This matrix includes R2 values describing the relation-
ships between metabolite concentration and reported signal intensity, as 
determined by MetabolomeExpress.
Raw data visualisation
Provides chromatogram visualisation + +
Chromatogram viewer displays TICs + +
Chromatogram viewer displays EICs +
Chromatogram viewer allows overlays of multiple 
chromatograms
+
Chromatogram viewer zoomable +
Provides MS spectral visualisation + +
Provides MS spectra of library entries + +
Provides MS spectra of arbitrary MS scans +
Features of MetabolomeExpress that distinguish it from the existing GC/MS metabolomics web-tools - PlantMetabolomics.org ([28]), SetupX [15], 
MeltDB [14] and MetaboAnalyst [13] - are listed. A '+' indicates that a feature is present. * We were unable to find any information indicating that 
any of the datasets stored in PlantMetabolomics.org have been published in peer-reviewed, biology-focused research articles.
Table 2: Features distinguishing MetabolomeExpress from existing GC/MS metabolomics web-tools. (Continued)
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